60 Degrees Pharma to Vote on Reverse Split, Equity Plan, Management Fee

60 Degrees Pharmaceuticals, Inc. announced its 2026 Annual Meeting of Stockholders to be held virtually on August 5, 2026. Key proposals include the election of five directors, an amendment to increase the shares available under the 2022 Equity Incentive Plan by 800,000, and an amendment to effect a reverse stock split at a ratio of 1:5 to 1:10. Stockholders will also vote on ratifying the independent auditor and approving a management success fee of 5-6% of deal proceeds for certain strategic transactions or the sale of Arakoda.